Medications for Crohn's Disease
See also: sub-topics
Drugs used to treat Crohn's Disease
The following list of medications are in some way related to or used in the treatment of this condition.
Drug name | Rating | Reviews | Activity ? | Rx/OTC | Pregnancy | CSA | Alcohol |
---|---|---|---|---|---|---|---|
Remicade | 5.1 | 16 reviews | Rx | ||||
Generic name: infliximab systemic Drug class: antirheumatics, TNF alfa inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Humira | 4.6 | 58 reviews | Rx | ||||
Generic name: adalimumab systemic Drug class: antirheumatics, TNF alfa inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
mesalamine Off-label | 7.1 | 32 reviews | Rx | ||||
Generic name: mesalamine systemic Drug class: 5-aminosalicylates For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information Off-label: Yes |
|||||||
Entyvio | 6.1 | 49 reviews | Rx | ||||
Generic name: vedolizumab systemic Drug class: selective immunosuppressants For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
sulfasalazine Off-label | 7.9 | 12 reviews | Rx | ||||
Generic name: sulfasalazine systemic Drug class: antirheumatics, 5-aminosalicylates For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information Off-label: Yes |
|||||||
azathioprine | 5.5 | 13 reviews | Rx | ||||
Generic name: azathioprine systemic Brand names: Imuran, Azasan Drug class: antirheumatics, other immunosuppressants For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
Cimzia | 6.5 | 4 reviews | Rx | ||||
Generic name: certolizumab systemic Drug class: TNF alfa inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
budesonide | 6.3 | 17 reviews | Rx | ||||
Generic name: budesonide systemic Brand names: Entocort EC, Ortikos Drug class: inhaled corticosteroids, glucocorticoids For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
Stelara | 5.8 | 53 reviews | Rx | ||||
Generic name: ustekinumab systemic Drug class: interleukin inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
vedolizumab | 5.9 | 57 reviews | Rx | ||||
Generic name: vedolizumab systemic Brand name: Entyvio Drug class: selective immunosuppressants For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph |
|||||||
certolizumab | 6.5 | 4 reviews | Rx | ||||
Generic name: certolizumab systemic Brand name: Cimzia Drug class: TNF alfa inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph |
|||||||
Entocort EC | 7.6 | 6 reviews | Rx | ||||
Generic name: budesonide systemic Drug class: glucocorticoids For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Renflexis | Rate | Add review | Rx | ||||
Generic name: infliximab systemic Drug class: TNF alfa inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Avsola | Rate | Add review | Rx | ||||
Generic name: infliximab systemic Drug class: TNF alfa inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
hyoscyamine Off-label | 9.3 | 4 reviews | Rx | ||||
Generic name: hyoscyamine systemic Drug class: anticholinergics/antispasmodics For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information Off-label: Yes |
|||||||
Imuran | 3.3 | 6 reviews | Rx | ||||
Generic name: azathioprine systemic Drug class: antirheumatics, other immunosuppressants For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
risankizumab | 6.0 | 2 reviews | Rx | ||||
Generic name: risankizumab systemic Brand name: Skyrizi Drug class: interleukin inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph |
|||||||
Skyrizi | 8.0 | 1 review | Rx | ||||
Generic name: risankizumab systemic Drug class: interleukin inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
cholestyramine Off-label | 9.3 | 17 reviews | Rx | ||||
Generic name: cholestyramine systemic Drug class: bile acid sequestrants For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph Off-label: Yes |
|||||||
infliximab | 4.1 | 28 reviews | Rx | ||||
Generic name: infliximab systemic Brand names: Remicade, Renflexis, Avsola, Inflectra, Ixifi …show all Drug class: antirheumatics, TNF alfa inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
adalimumab | 4.5 | 59 reviews | Rx | ||||
Generic name: adalimumab systemic Brand names: Humira, Amjevita, Cyltezo, Abrilada, Hadlima, Hulio, Hyrimoz, Yusimry, Idacio …show all Drug class: antirheumatics, TNF alfa inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph |
|||||||
Azasan | 10 | 1 review | Rx | ||||
Generic name: azathioprine systemic Drug class: antirheumatics, other immunosuppressants For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
rifaximin Off-label | 9.3 | 7 reviews | Rx | ||||
Generic name: rifaximin systemic Drug class: miscellaneous antibiotics For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph Off-label: Yes |
|||||||
Ortikos | Rate | Add review | Rx | ||||
Generic name: budesonide systemic Drug class: glucocorticoids For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
tacrolimus Off-label | 8.5 | 3 reviews | Rx | ||||
Generic name: tacrolimus systemic Drug class: calcineurin inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information Off-label: Yes |
|||||||
Frequently asked questions
- Which is worse: Ulcerative colitis or Crohn's disease?
- What is low dose naltrexone (LDN)?
- Is Entyvio an immunosuppressant or a biologic?
- How much does Entyvio cost per month?
- How long does it take Entyvio to start working?
- Why is my poop green? What does this mean?
- How do you inject Humira?
Topics under Crohn's Disease
- Crohn's Disease, Acute (45 drugs)
- Crohn's Disease, Maintenance (35 drugs)
Learn more about Crohn's Disease
Care guides
Symptoms and treatments
Medicine.com guides (external)
Legend
Rating | For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). |
---|---|
Activity | Activity is based on recent site visitor activity relative to other medications in the list. |
Rx | Prescription only. |
OTC | Over-the-counter. |
Rx/OTC | Prescription or Over-the-counter. |
Off-label | This medication may not be approved by the FDA for the treatment of this condition. |
EUA | An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives. |
Expanded Access | Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available. |
Pregnancy Category | |
---|---|
A | Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
C | Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. |
N | FDA has not classified the drug. |
Controlled Substances Act (CSA) Schedule | |
---|---|
M | The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication. |
U | CSA Schedule is unknown. |
N | Is not subject to the Controlled Substances Act. |
1 | Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. |
2 | Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
3 | Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
4 | Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
5 | Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
Alcohol | |
---|---|
X | Interacts with Alcohol. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.